6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles

6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles

MPJE Core Concept: The Federal Controlled Substances Act mandates that every person or entity who manufactures, distributes, dispenses, imports, exports, or conducts research with controlled substances must obtain a specific DEA Registration unless explicitly exempted by law. Registration establishes accountability within the closed system of distribution.

---

Mandatory DEA Registration Categories & Required Forms

DEA registrations are issued for specific business activities. A registrant may only engage in the specific activities authorized under their issued registration category.

---

The Separate Location Rule & Co-Incident Activities

Separate Location Rule

Under 21 CFR § 1301.12, a separate DEA registration is required for each physical location where controlled substances are manufactured, distributed, stored, or dispensed. For example, a retail pharmacy chain operating 10 separate store locations in a city must apply for and maintain 10 individual DEA registrations.

Co-Incident Activities

Co-incident activities allow a registrant to engage in certain secondary activities without obtaining a separate DEA registration:

1. Manufacturers: A registered manufacturer (Form 225) may distribute controlled substances it manufactured and conduct research/chemical analysis on those substances co-incidentally.
2. Researchers: A registered researcher may conduct research and synthesize controlled substances specified in the approved research protocol.
3. Pharmacies & The 5% Distribution Rule: Under 21 CFR § 1307.11, a retail pharmacy registered to dispense controlled substances (Form 224) may distribute controlled substances to another pharmacy or registered practitioner for immediate office use without registering as a DEA distributor, provided that the total number of dosage units distributed does not exceed 5% of the total dosage units of all controlled substances dispensed and distributed by the pharmacy during the same calendar year. If the pharmacy exceeds the 5% limit at any point during the calendar year, it MUST register as a distributor using DEA Form 225.

---

Statutory Exemptions from DEA Registration

The following persons are statutorily exempt from obtaining an individual DEA registration:

1. Agents and Employees of Registrants: Staff pharmacists, pharmacy technicians, nurses, warehouse clerks, and delivery drivers acting within the normal course of employment under the employer's DEA registration.
2. Officials of Federal Agencies & Military: Medical officers of the U.S. Armed Forces (Army, Navy, Air Force, Marine Corps, Coast Guard), U.S. Public Health Service (USPHS), and Federal Bureau of Prisons (BOP) acting in the discharge of official duties.
   • Prescribing Rules for Military/USPHS Practitioners: Federal officials use their official service identification number (e.g., Social Security Number or military service ID) plus their branch of service on prescriptions. However, if a military practitioner engages in private off-base practice (moonlighting at a civilian hospital), they MUST obtain an individual civilian DEA registration.
3. Ultimate Users: Patients or animal owners who lawfully possess controlled substances dispensed for legitimate medical use.

---

Structure of DEA Registration Numbers

A valid DEA registration number consists of nine alphanumeric characters: 2 letters followed by 7 digits.

First Letter Designation

• A, B, F, G: Individual Practitioners (Physicians, Dentists, Podiatrists, Veterinarians), Hospitals, Clinics, Retail Pharmacies. (Letter G is designated specifically for Department of Defense / Government practitioners.)
• M: Mid-Level Practitioners (MLPs: Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Clinical Nurse Specialists, Optometrists).
• P, R: Manufacturers, Distributors, Importers, Exporters, Researchers, Reverse Distributors.

Second Letter Designation

Usually the first letter of the registrant's last name (for individual practitioners) or the first letter of the business name (for pharmacies, hospitals, or corporations). If a business name begins with a number, the second character may be a digit.

---

Mathematical Verification Algorithm for DEA Numbers

MPJE exams frequently test the step-by-step mathematical algorithm used to verify the legitimacy of a 7-digit DEA number (let the digits be $d_1 d_2 d_3 d_4 d_5 d_6 d_7$):

$\text{Step 1: Add the 1st, 3rd, and 5th digits} \longrightarrow S_1 = d_1 + d_3 + d_5$ $\text{Step 2: Add the 2nd, 4th, and 6th digits, then multiply by 2} \longrightarrow S_2 = (d_2 + d_4 + d_6) \times 2$ $\text{Step 3: Add the Step 1 total to the Step 2 total} \longrightarrow S_{\text{total}} = S_1 + S_2$ $\text{Step 4: Check digit verification} \longrightarrow \text{The last digit of } S_{\text{total}} \text{ MUST equal the 7th digit } (d_7)$

Example Mathematical Verification

Consider a practitioner named Dr. Jane Smith with DEA number BS1352462:

• $S_1 = 1 + 5 + 4 = 10$
• $S_2 = (3 + 2 + 6) \times 2 = 11 \times 2 = 22$
• $S_{\text{total}} = 10 + 22 = 32$
• The last digit of $32$ is 2, which matches the 7th digit ($d_7 = 2$). The DEA number is mathematically valid.

---

Business Modifications, Transfers & Registration Termination

Change of Address / Business Name

If a pharmacy or practitioner changes their physical business address or name, they must submit a modification request to the DEA online or in writing prior to the move. If approved, the DEA issues an updated Registration Certificate bearing the new address while retaining the original DEA number.

Discontinuation of Business & Inventory Transfer

When a registrant discontinues business without transferring to another owner, the DEA certificate and all unused DEA Form 222 order forms must be returned to the local DEA registration specialist. Controlled substance inventory must be destroyed or transferred in accordance with DEA regulations.

Transfer of Business to Another Registrant

A registrant proposing to transfer their pharmacy business and controlled substance inventory to another registrant must notify the regional DEA Special Agent in Charge at least 14 days in advance of the proposed transfer. On the day of transfer, a complete controlled substance inventory must be taken (CII written inventory separate from CIII-CV), and a copy must be maintained by both transferor and transferee.